(Q46599326)

English

Influenza vaccination and major adverse vascular events in high-risk patients

scientific article published on 19 June 2012

Statements

Influenza vaccination and major adverse vascular events in high-risk patients (English)
Ongoing Telmisartan Alone and in Combination With Ramipril Global EndPoint Trial (ONTARGET)
Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease (TRANSCEND) Investigators

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit